ATS 2018 International Conference - Mobile

The Motion Study to Assess the Effect of Riociguat on Patient-Reported Outcomes in PAH: Correlations Between the Living with Pulmonary Hypertension Questionnaire and Secondary Endpoints [Board No. P126]

Location: Board no. P126

Session Type: Thematic Poster Session

Sunday

May

20

11:15 AM

1:00 PM

Speaker(s)/Author(s)

Franck F. Rahaghi

MD
Cleveland Clinic Florida

David M. Platt

MD
Bayer HealthCare Pharmaceuticals Inc

Gerald M. O'Brien

MD
Bayer HealthCare Pharmaceuticals Inc

Frank Kleinjung

PhD
Bayer AG

Lana Melendres-Groves

MD
Internal medicine;University of New Mexico

Anneliese LaRose

MS
Bayer HealthCare Pharmaceuticals Inc

View Abstract

The Motion Study to Assess the Effect of Riociguat on Patient-Reported Outcomes in PAH: Correlations Between the Living with Pulmonary Hypertension Questionnaire and Secondary Endpoints

Parent Sessions

A64 - LET'S GO TRIPPIN': DIAGNOSTICS AND RISK ASSESSMENT IN PULMONARY HYPERTENSION...
05-20-2018 9:15 AM - 4:15 PM